Prolytix, formerly Haematologic Technologies, has 30+ years of experience in protein chemistry, which ensures our team will identify and solve the challenges of your large molecule product. Our services in research and development, characterization by high-resolution mass spectrometry (HRMS), GxP testing, and custom collection devices assist clients worldwide. Using an agile, consultative approach, we support your product’s development from discovery through GMP release. With our proven CMC and regulatory expertise from IND through BLA to our accessible, attentive, and seasoned team, Prolytix is the go-to partner for protein therapeutic projects from routine to complex. For advanced protein development, go with the pro — Prolytix. To learn more about our expertise, services, and products, visit GoProlytix.com.
External link for Prolytix
57 River Road
Essex Junction, Vermont 05452, US
Day 2 and another Prolytix Poster highlighting the solutions we are crafting for our clients!
Bringing the best kept secret in supporting your product's development from discovery through GMP release with 30+ years experience. Senior Director Business Development at Prolytix.
Matthew F. Whelihan crushing his poster presentation.
Day 1 at AAPS in Salt Lake City. Joseph Campbell, Ph.D shows off his poster.
Bringing the best kept secret in supporting your product's development from discovery through GMP release with 30+ years experience. Senior Director Business Development at Prolytix.
Day 1 at AAPS in Salt Lake City. Joseph Campbell, Ph.D shows off his poster.
If you're attending Immunogenicity Summit, grab one of our info sheets to learn more about our BioA Capabilities.
Bringing the best kept secret in supporting your product's development from discovery through GMP release with 30+ years experience. Senior Director Business Development at Prolytix.
Prolytix is proud to be sharing on Day 2.
Prolytix has over 30 years of industry experience developing and validating analytical methods to support IVIG Therapeutics. Our COO, Ryan Dorfman, Ph.D. will be speaking this Saturday at IGNS on our industry experience. To learn more about our IVIG Analytical Capabilities, click here: https://lnkd.in/eun9v6yC #IVIG, #IGNS, #Analytical
We’re excited for this year’s IgNS National Conference, October 17-20. If you’re attending, stop by booth 100 to see why. We also hope you will join us for a 60-minute breakfast symposium Advancing the IVIG Manufacturing Process With Cation Exchange (CEX) Chromatography on Saturday, October 19, 2024, starting at 8am EST. Hosted by a panel of seasoned experts who each bring a unique perspective. •Ryan Dorfman, Ph.D., is a seasoned expert in pharmaceutical product development, analytical method development, and the manufacturing of reagents and custom collection devices. His vast technical expertise spans multiple disciplines, including protein biochemistry, enzymology, blood coagulation, and analytical method development. •Dr. Stacey Ness is currently serving on the Medical Affairs team at GC Biopharma USA. She brings to us significant experience in specialty pharmacy and in the clinical management of chronic diseases and has special interest in working with patient advocacy and support groups. •Suzanne Strasters, MSN-FNP, IgCN is a Nurse Practitioner with extensive experience in clinical nursing, specializing in Ig infusion therapies and providing clinical education to nurses, clinical staff and patients on various Ig therapies. Currently, Suzanne is serving as the Head of Clinical Education for GC Biopharma USA. We’ll be sharing information about our latest therapy including safety, efficacy, and indication, as well as best practices for administration. We hope to see you in Washington DC.
One week away from PharmSci360 in Salt Lake City! Visit us at BOOTH #1713 to learn how our team, along with our partner Allumiqs, is leveraging the power of Multi-Omics in analytical biomarker and release testing. We look forward to connecting with you and sharing our insights. Don’t miss out! Be sure to check out our Poster Presentations! Joseph Campbell, Ph.D: (M1330-10-58) A Multiple Component, Indirect Analysis of Ammonium: Analysis of Sulfate Ion in a Commercial Biotherapeutic via HPLC to Measure Ammonium Content Matthew F. Whelihan: (T1130-11-64) Successful Validation of a Thrombin Generation Assay (TGA) for the Release of an Intravenous Immunoglobulin (IVIG) Drug #AAPS2024, #PharmSci360, #PharmaceuticalScience, #DrugDevelopment, #Bioanalysis, #GMP, #AnalyticalChemistry
We're less than 1 week away from the start of Immunogenicity Summit 2024! Be sure to check out our poster: P13: Development of ADA ELISA Utilizing ACE Method to Increase Drug Tolerance and Assay Sensitivity, Presented by Danielle C. Come and chat with James Moore to explore the innovative advancements Prolytix is making in immunogenicity testing. We’d love to hear your insights!
Excitement is building—only two weeks until PharmSci in SLC! Come visit us at booth #1713 to see how Prolytix is transforming Large Molecule BioA and GMP Release Assays. Discover innovative solutions that can elevate your work! We’re eager to connect and show you what we can do together! #PharmSci, #BioA, #GMP
To celebrate 17 years of ISO certification, we're offering new customers 17% off our quality research reagents for 17 days. Our product line includes human proteins, bovine proteins, antibodies, and associated reagents for thrombosis research and in vitro diagnostic applications. Connect with our team now: https://lnkd.in/ejGH66ZM #largemoleculeresearch #biopharmaceuticals #drugdevelopment #researchreagents #biotechsupplies